Pfizer Looks To Give J&J/Merck Heartburn With Zantac 150 Switch
This article was originally published in The Tan Sheet
Executive Summary
Pfizer Consumer Healthcare's Rx-to-OTC switch of Zantac 150 appears to be a belated attempt to counter Johnson & Johnson/Merck's approval of Maximum Strength Pepcid AC last year